AAAAAA

   
Results: 1-19 |
Results: 19
Evidence based case report - Advice about mammography for a young woman with a family history of breast cancer
Authors: Lucassen, A Watson, E Eccles, D
Citation: A. Lucassen et al., Evidence based case report - Advice about mammography for a young woman with a family history of breast cancer, BR MED J, 322(7293), 2001, pp. 1040-1042
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22
Authors: Rahman, N Teare, MD Seal, S Renard, H Mangion, J Cour, C Thompson, D Shugart, Y Eccles, D Devilee, P Meijers, H Nathanson, KL Neuhausen, SL Weber, B Chang-Claude, J Easton, DF Goldgar, D Stratton, MR
Citation: N. Rahman et al., Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22, ONCOGENE, 19(36), 2000, pp. 4170-4173
A new case of frontotemporal dementia and parkinsonism resulting from an intron 10+3-splice site mutation in the tau gene: clinical and pathological features
Authors: Tolnay, M Spillantini, MG Rizzini, C Eccles, D Lowe, J Ellison, D
Citation: M. Tolnay et al., A new case of frontotemporal dementia and parkinsonism resulting from an intron 10+3-splice site mutation in the tau gene: clinical and pathological features, NEUROP AP N, 26(4), 2000, pp. 368-378
A survey of the current clinical facilities for the management of familialcancer in Europe
Authors: Hodgson, SV Haites, NE Caligo, M Chang-Claude, J Eccles, D Evans, G Moller, P Morrison, P Steel, CM Stoppa-Lyonnet, D Vasen, H
Citation: Sv. Hodgson et al., A survey of the current clinical facilities for the management of familialcancer in Europe, J MED GENET, 37(8), 2000, pp. 605-607
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis
Authors: Woodford-Richens, K Bevan, S Churchman, M Dowling, B Jones, D Norbury, CG Hodgson, SV Desai, D Neale, K Phillips, RKS Young, J Leggett, B Dunlop, M Rozen, P Eng, C Markie, D Rodriguez-Bigas, MA Sheridan, E Iwama, T Eccles, D Smith, GT Kim, JC Kim, KM Sampson, JR Evans, G Tejpar, S Bodmer, WF Tomlinson, IPM Houlston, RS
Citation: K. Woodford-richens et al., Analysis of genetic and phenotypic heterogeneity in juvenile polyposis, GUT, 46(5), 2000, pp. 656-660
Diagnosis and management of haemochromatosis since the discovery of the HFE gene: A European experience
Authors: Robson, KJH Merryweather-Clark, AT Pointon, JJ Shearman, JD Halsall, DJ Kelly, A Cox, TM Rosenberg, WM Howell, M Eccles, D Patch, C Fowler, AV Wallace, DF Camaschella, C Roetto, A Zecchina, G De Gobbi, M Gasparini, P Cadet, E Vandwalle, JL Capron, D Rochette, J Borot, N Demangel, C Dery, R Vinel, JP Pascal, JP Coppin, H Roth, MP
Citation: Kjh. Robson et al., Diagnosis and management of haemochromatosis since the discovery of the HFE gene: A European experience, BR J HAEM, 108(1), 2000, pp. 31-39
Hereditary haemochromatosis should be more widely known about
Authors: Rosenberg, W Howell, M Roderick, P Eccles, D Day, I
Citation: W. Rosenberg et al., Hereditary haemochromatosis should be more widely known about, BR MED J, 318(7196), 1999, pp. 1486-1487
Cancer genetics services in Europe
Authors: Hodgson, S Milner, B Brown, I Bevilacqua, G Chang-Claude, J Eccles, D Evans, G Gregory, H Moller, P Morrison, P Steel, M Stoppa-Lyonnet, D Vasen, H Haites, N
Citation: S. Hodgson et al., Cancer genetics services in Europe, DIS MARKER, 15(1-3), 1999, pp. 3-13
Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Stoppa-Lyonnet, D Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics, DIS MARKER, 15(1-3), 1999, pp. 47-47
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes
Authors: Chang-Claude, J Becher, H Caligo, M Eccles, D Evans, G Haites, N Hodgson, S Moller, P Weber, BHF Stoppa-Lyonnet, D
Citation: J. Chang-claude et al., Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes, DIS MARKER, 15(1-3), 1999, pp. 53-65
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Authors: Stoppa-Lyonnet, D Caligo, M Eccles, D Evans, DGR Haites, NE Hodgson, NS Moller, P Morrison, PJ Steel, CM Vasen, HFA Chang-Claude, J
Citation: D. Stoppa-lyonnet et al., Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?, DIS MARKER, 15(1-3), 1999, pp. 67-68
Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project
Authors: Steel, M Smyth, E Vasen, H Eccles, D Evans, G Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Morrison, P Haites, N
Citation: M. Steel et al., Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project, DIS MARKER, 15(1-3), 1999, pp. 125-131
Utilisation of prophylactic mastectomy in 10 European centers
Authors: Evans, DGR Anderson, E Lalloo, F Vasen, H Beckmann, M Eccles, D Hodgson, S Moller, P Chang-Claude, J Morrison, P Stoppa-Lyonnet, D Steel, M Haites, N
Citation: Dgr. Evans et al., Utilisation of prophylactic mastectomy in 10 European centers, DIS MARKER, 15(1-3), 1999, pp. 148-151
Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe
Authors: Morrison, PJ Steel, CM Vasen, HFA Eccles, D Evans, DGR Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Olah, E Haites, NE Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165
Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
Authors: Moller, P Evans, G Haites, N Vasen, H Reis, MM Anderson, E Apold, J Hodgson, S Eccles, D Olsson, H Stoppa-Lyonnet, D Chang-Claude, J Morrison, PJ Bevilacqua, G Heimdal, K Maehle, L Lalloo, F Gregory, H Preece, P Borg, A Nevin, NC Caligo, M Steel, CM
Citation: P. Moller et al., Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer, DIS MARKER, 15(1-3), 1999, pp. 207-211
Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer
Authors: Shugart, YY Cour, C Renard, H Lenoir, G Goldgar, D Teare, D Easton, D Rahman, N Gusterton, R Seal, S Barfoot, R Stratton, M Mangion, J Peelen, T van den Ouweland, A Meijers, H Devilee, P Eccles, D Lynch, H Weber, B Stoppa-Lyonnet, D Bignon, YJ
Citation: Yy. Shugart et al., Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer, J MED GENET, 36(9), 1999, pp. 720-721
Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome
Authors: Bevan, S Woodford-Richens, K Rozen, P Eng, C Young, J Dunlop, M Neale, K Phillips, R Markie, D Rodriguez-Bigas, M Leggett, B Sheridan, E Hodgson, S Iwama, T Eccles, D Bodmer, W Houlston, R Tomlinson, I
Citation: S. Bevan et al., Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome, GUT, 45(3), 1999, pp. 406-408
Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Lyonet, DS Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics, EUR J CANC, 34(12), 1998, pp. 1922-1926
Concerted action polyp prevention, CAPP2: A trial of aspirin and/or resistant starch in people at risk of hereditary non-polyposis colon cancer (HNPCC)
Authors: Burn, J Alonso, A Bertario, L Bishop, T Bisgaard, ML Cummings, J Davidson, R Delhanty, J Demant, P Dunlop, M Eccles, D Ellis, A Evans, G Fidalgo, P Fodde, R Haites, N Hodgson, S Hultcrantz, R Huson, S Jarvinen, H Kartheuser, A Kleibeuker, J Lenaerts, C Lucasson, A Lunt, P McDermot, K McKay, J McKeown, C Maher, E Mathers, J Mecklin, JP Moslein, G Murday, V Nagengast, F Northover, JMA Obrador, A Parks, TG Paraskeva, C Phillips, R San Roman, C Ruscheoff, J Sampson, J Shepherd, N Tempesta, A Trembath, R Turnpenny, P Vasen, HFA
Citation: J. Burn et al., Concerted action polyp prevention, CAPP2: A trial of aspirin and/or resistant starch in people at risk of hereditary non-polyposis colon cancer (HNPCC), BIOM HLTH R, 24, 1998, pp. 17-23
Risultati: 1-19 |